PHEROZETAMBOLIPHEROZE TAMBOLI8780TAMBOLI, PHEROZEProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson23006314Guo H, Liu W, Ju Z, Tamboli P, Jonasch E, Mills GB, Lu Y, Hennessy BT, Tsavachidou DProteome scienceAn efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays. Proteome Sci. 2012 Sep 24; 10(1):56.Proteome Sci2012-09-24T00:00:002012An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays.1515 Holcombe BlvdHouston77030-4009TXAuthorship 1690443Authorship 1713711Authorship 1717408Authorship 1728613Authorship 1734345Authorship 1771733Authorship 1777342Authorship 1782203Authorship 1806705Authorship 1812684Authorship 1816205Authorship 1816263Authorship 1816693Authorship 1820324Authorship 1846344Authorship 1846915Authorship 1852723Authorship 1859562Authorship 1862372Authorship 1863264Authorship 1868353Authorship 1880243Authorship 1884884Authorship 1887287Authorship 1912956Authorship 1916314Authorship 1931761Authorship 1941145Authorship 1945055Authorship 19555019Authorship 1956096Authorship 196015510976704Philip AT, Amin MB, Tamboli P, Lee TJ, Hill CE, Ro JYThe American journal of surgical pathologyIntravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis. Am J Surg Pathol. 2000 Sep; 24(9):1286-90.Am J Surg Pathol2000-09-01T00:00:002000Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis.12715337Ramalingam P, Middleton LP, Tamboli P, Troncoso P, Silva EG, Ayala AGAnnals of diagnostic pathologyInvasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ann Diagn Pathol. 2003 Apr; 7(2):112-9.Ann Diagn Pathol2003-04-01T00:00:002003Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.12826898Vollmer RTThe American journal of surgical pathologyImpact of histologic subtyping of renal epithelial neoplasms. Am J Surg Pathol. 2003 Jul; 27(7):1021-2; author reply 1022-4.Am J Surg Pathol2003-07-01T00:00:002003Impact of histologic subtyping of renal epithelial neoplasms.12970754Copland JA, Luxon BA, Ajani L, Maity T, Campagnaro E, Guo H, LeGrand SN, Tamboli P, Wood CGOncogeneGenomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression. Oncogene. 2003 Sep 11; 22(39):8053-62.Oncogene2003-09-11T00:00:002003Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.15569050Abrahams NA, MacLennan GT, Khoury JD, Ormsby AH, Tamboli P, Doglioni C, Schumacher B, Tickoo SKHistopathologyChromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology. 2004 Dec; 45(6):593-602.Histopathology2004-12-01T00:00:002004Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.17420980Margulis V, S?nchez-Ortiz RF, Tamboli P, Cohen DD, Swanson DA, Wood CGCancerRenal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management. Cancer. 2007 May 15; 109(10):2025-30.Cancer2007-05-15T00:00:002007Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management.17482917Kassouf W, Sanchez-Ortiz R, Tamboli P, Jonasch E, Merchant MM, Spiess PE, Wood CGUrologyCytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience. Urology. 2007 May; 69(5):835-8.Urology2007-05-01T00:00:002007Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.18806169Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CMAJR. American journal of roentgenologyRenal cell carcinoma: diagnosis, staging, and surveillance. AJR Am J Roentgenol. 2008 Oct; 191(4):1220-32.AJR Am J Roentgenol2008-10-01T00:00:002008Renal cell carcinoma: diagnosis, staging, and surveillance.18950837Margulis V, Matin SF, Tannir N, Tamboli P, Shen Y, Lozano M, Swanson DA, Jonasch E, Wood CGUrologyRandomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma. Urology. 2009 Feb; 73(2):337-41.Urology2008-10-31T00:00:002008Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma.19448113Vikram R, Ng CS, Tamboli P, Tannir NM, Jonasch E, Matin SF, Wood CG, Sandler CMRadiographics : a review publication of the Radiological Society of North America, IncPapillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics. 2009 May-Jun; 29(3):741-54; discussion 755-7.Radiographics2009-05-01T00:00:002009Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease.19521957Chen M, Ye Y, Yang H, Tamboli P, Matin S, Tannir NM, Wood CG, Gu J, Wu XInternational journal of cancerGenome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int J Cancer. 2009 Nov 15; 125(10):2342-8.Int J Cancer2009-11-15T00:00:002009Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.19578046Chaux A, Lezcano C, Cubilla AL, Tamboli P, Ro J, Ayala AInternational journal of surgical pathologyComparison of subtypes of penile squamous cell carcinoma from high and low incidence geographical regions. Int J Surg Pathol. 2010 Aug; 18(4):268-77.Int J Surg Pathol2009-07-03T00:00:002009Comparison of subtypes of penile squamous cell carcinoma from high and low incidence geographical regions.20004935Nicolas MM, Tamboli P, Gomez JA, Czerniak BAHuman pathologyPleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Hum Pathol. 2010 May; 41(5):663-71.Hum Pathol2009-12-11T00:00:002009Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases.20089566Tsavachidou-Fenner D, Tannir N, Tamboli P, Liu W, Petillo D, Teh B, Mills GB, Jonasch EAnnals of oncology : official journal of the European Society for Medical OncologyGene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma. Ann Oncol. 2010 Aug; 21(8):1599-1606.Ann Oncol2010-01-20T00:00:002010Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma.20564061Culp SH, Tannir NM, Abel EJ, Margulis V, Tamboli P, Matin SF, Wood CGCancerCan we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer. 2010 Jul 15; 116(14):3378-88.Cancer2010-07-15T00:00:002010Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?20971497Dhillon J, Tannir NM, Matin SF, Tamboli P, Czerniak BA, Guo CCHuman pathologyThyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol. 2011 Jan; 42(1):146-50.Hum Pathol2010-10-23T00:00:002010Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes.21071373Katabathina VS, Vikram R, Nagar AM, Tamboli P, Menias CO, Prasad SRRadiographics : a review publication of the Radiological Society of North America, IncMesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. Radiographics. 2010 Oct; 30(6):1525-40.Radiographics2010-10-01T00:00:002010Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation.21167632Karam JA, Zhang XY, Tamboli P, Margulis V, Wang H, Abel EJ, Culp SH, Wood CGEuropean urologyDevelopment and characterization of clinically relevant tumor models from patients with renal cell carcinoma. Eur Urol. 2011 Apr; 59(4):619-28.Eur Urol2010-12-08T00:00:002010Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.21944129Tan W, Hildebrandt MA, Pu X, Huang M, Lin J, Matin SF, Tamboli P, Wood CG, Wu XThe Journal of urologyRole of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes. J Urol. 2011 Nov; 186(5):2071-7.J Urol2011-09-23T00:00:002011Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes.22266464Hildebrandt MA, Tan W, Tamboli P, Huang M, Ye Y, Lin J, Lee JS, Wood CG, Wu XCarcinogenesisKinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients. Carcinogenesis. 2012 Apr; 33(4):799-803.Carcinogenesis2012-01-19T00:00:002012Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients.Genitourinary Medical OncologyMD AndersonCHRISTOPHER GWOODCHRISTOPHER G WOOD8666WOOD, CHRISTOPHER GProfessorERICJONASCHERIC JONASCH9049JONASCH, ERICProfessor5.860250.0067415506research areas4.405010.0145876101coauthor of303.99219.079360similar to11207selected publicationsPRIYARAOPRIYA RAO9509RAO, PRIYAAssociate ProfessorNIZAR MTANNIRNIZAR M TANNIR8865TANNIR, NIZAR MProfessorSURENAMATINSURENA MATIN9030MATIN, SURENAProfessorJOSE ANTONIOKARAMJOSE ANTONIO KARAM9608KARAM, JOSE ANTONIOAssociate ProfessorAuthorship 2152841Authorship 2154564Authorship 2157571Authorship 2175783Authorship 2197862Authorship 2206063Authorship 222368Authorship 2229622Authorship 2229666Authorship 2233222Authorship 2239313Authorship 2243212Authorship 2248244Authorship 2254676Authorship 2262472Authorship 2268513Authorship 2269778Authorship 22748310Authorship 2275222Authorship 2289114Authorship 2293975Authorship 22955915Authorship 2297083Authorship 2299066Authorship 2301294Authorship 2304995Authorship 2305867Authorship 2306694Authorship 2321229Authorship 232660158633403Stricker HJ, Jay JK, Linden MD, Tamboli P, Amin MBUrologyDetermining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53. Urology. 1996 Mar; 47(3):366-9.Urology1996-03-01T00:00:001996Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53.8902840Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus JModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncComparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Mod Pathol. 1996 Oct; 9(10):1015-9.Mod Pathol1996-10-01T00:00:001996Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.9521470Tamboli P, Amin MB, Xu HJ, Linden MDModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncImmunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate. Mod Pathol. 1998 Mar; 11(3):247-52.Mod Pathol1998-03-01T00:00:001998Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.10492179Javidan J, Stricker HJ, Tamboli P, Amin MB, Peabody JO, Deshpande A, Menon M, Amin MBThe Journal of urologyPrognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol. 1999 Oct; 162(4):1277-81.J Urol1999-10-01T00:00:001999Prognostic significance of the 1997 TNM classification of renal cell carcinoma.12216089Che M, Tamboli P, Ro JY, Park DS, Ro JS, Amato RJ, Ayala AGCancerBilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center. Cancer. 2002 Sep 15; 95(6):1228-33.Cancer2002-09-15T00:00:002002Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.15076299Kamat AM, Plager C, Tamboli P, Tran N, Pettaway CAThe Journal of urologyMetastatic epithelioid hemangioendothelioma of the penis managed with surgery and interferon-alpha. J Urol. 2004 May; 171(5):1886-7.J Urol2004-05-01T00:00:002004Metastatic epithelioid hemangioendothelioma of the penis managed with surgery and interferon-alpha.15879790S?nchez-Ortiz R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway CAThe Journal of urologyMelanoma of the penis, scrotum and male urethra: a 40-year single institution experience. J Urol. 2005 Jun; 173(6):1958-65.J Urol2005-06-01T00:00:002005Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.15897741Skinnider BF, Folpe AL, Hennigar RA, Lim SD, Cohen C, Tamboli P, Young A, de Peralta-Venturina M, Amin MBThe American journal of surgical pathologyDistribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol. 2005 Jun; 29(6):747-54.Am J Surg Pathol2005-06-01T00:00:002005Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors.16096414Epstein JI, Allsbrook WC, Amin MB, Egevad LL, ISUP Grading CommitteeThe American journal of surgical pathologyThe 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005 Sep; 29(9):1228-42.Am J Surg Pathol2005-09-01T00:00:002005The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.17296358Kader AK, Tamboli P, Luongo T, Matin SF, Bell K, Jonasch E, Swanson DA, Wood CGThe Journal of urologyCytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience. J Urol. 2007 Mar; 177(3):855-60; discussion 860-1.J Urol2007-03-01T00:00:002007Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience.17542024Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LLCancerMicropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer. 2007 Jul 01; 110(1):62-7.Cancer2007-07-01T00:00:002007Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.17804784Javadi S, Matin SF, Tamboli P, Ahrar KJournal of vascular and interventional radiology : JVIRUnexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol. 2007 Sep; 18(9):1186-91.J Vasc Interv Radiol2007-09-01T00:00:002007Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy.17868733Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CGThe Journal of urologyLocation of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. J Urol. 2007 Nov; 178(5):1878-82.J Urol2007-09-17T00:00:002007Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.18190828Booth J, Matin SF, Ahrar K, Tamboli P, Wood CGUrologic oncologyContemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques. Urol Oncol. 2008 Jan-Feb; 26(1):37-42.Urol Oncol2007-11-26T00:00:002007Contemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques.18362942Jonasch E, Wood C, Tamboli P, Pagliaro LC, Tu SM, Kim J, Srivastava P, Perez C, Isakov L, Tannir NBritish journal of cancerVaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings. Br J Cancer. 2008 Apr 22; 98(8):1336-41.Br J Cancer2008-03-25T00:00:002008Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings.19123738Guo CC, Tamboli P, Czerniak BArchives of pathology & laboratory medicineMicropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases. Arch Pathol Lab Med. 2009 Jan; 133(1):62-6.Arch Pathol Lab Med2009-01-01T00:00:002009Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases.19492895Adeniran AJ, Tamboli PArchives of pathology & laboratory medicineClear cell adenocarcinoma of the urinary bladder: a short review. Arch Pathol Lab Med. 2009 Jun; 133(6):987-91.Arch Pathol Lab Med2009-06-01T00:00:002009Clear cell adenocarcinoma of the urinary bladder: a short review.19636008Jonasch E, Wood CG, Matin SF, Tu SM, Pagliaro LC, Corn PG, Aparicio A, Tamboli P, Millikan RE, Wang X, Araujo JC, Arap W, Tannir NJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol. 2009 Sep 01; 27(25):4076-81.J Clin Oncol2009-07-27T00:00:002009Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.19837433Svatek RS, Munsell M, Kincaid JM, Hegarty P, Slaton JW, Busby JE, Gaston KE, Spiess PE, Pagliaro LC, Tamboli P, Pettaway CAThe Journal of urologyAssociation between lymph node density and disease specific survival in patients with penile cancer. J Urol. 2009 Dec; 182(6):2721-7.J Urol2009-10-17T00:00:002009Association between lymph node density and disease specific survival in patients with penile cancer.20394619Abel EJ, Culp SH, Meissner M, Matin SF, Tamboli P, Wood CGBJU internationalIdentifying the risk of disease progression after surgery for localized renal cell carcinoma. BJU Int. 2010 Nov; 106(9):1277-83.BJU Int2010-11-01T00:00:002010Identifying the risk of disease progression after surgery for localized renal cell carcinoma.20665500Choueiri TK, Lim ZD, Hirsch MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NMCancerVascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma. Cancer. 2010 Nov 15; 116(22):5219-25.Cancer2010-11-15T00:00:002010Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.20717002Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Lopez-Beltran A, Oliva E, Paner GP, Reuter VE, Ro JY, Shah RB, Shen SS, Tamboli P, McKenney JKThe American journal of surgical pathologyInterobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol. 2010 Sep; 34(9):1367-76.Am J Surg Pathol2010-09-01T00:00:002010Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists.20732906Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu XCarcinogenesisGenetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis. 2010 Oct; 31(10):1805-12.Carcinogenesis2010-08-23T00:00:002010Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma.20830770Abou Youssif T, Fahmy MA, Koumakpayi IH, Ayala F, Al Marzooqi S, Chen G, Tamboli P, Squire J, Tanguay S, Sircar KCancerThe mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases. Cancer. 2011 Jan 15; 117(2):290-300.Cancer2010-09-09T00:00:002010The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases.21115604Richey SL, Culp SH, Jonasch E, Corn PG, Pagliaro LC, Tamboli P, Patel KK, Matin SF, Wood CG, Tannir NMAnnals of oncology : official journal of the European Society for Medical OncologyOutcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy. Ann Oncol. 2011 May; 22(5):1048-1053.Ann Oncol2010-11-29T00:00:002010Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy.21733553Si Q, Dancer J, Stanton ML, Tamboli P, Ro JY, Czerniak BA, Shen SS, Guo CCHuman pathologySmall cell carcinoma of the kidney: a clinicopathologic study of 14 cases. Hum Pathol. 2011 Nov; 42(11):1792-8.Hum Pathol2011-11-01T00:00:002011Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases.21784574Abel EJ, Culp SH, Tannir NM, Tamboli P, Matin SF, Wood CGEuropean urologyEarly primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib. Eur Urol. 2011 Dec; 60(6):1273-9.Eur Urol2011-07-14T00:00:002011Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib.22503066Abel EJ, Carrasco A, Culp SH, Matin SF, Tamboli P, Tannir NM, Wood CGBJU internationalLimitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases. BJU Int. 2012 Dec; 110(11):1742-6.BJU Int2012-04-13T00:00:002012Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.22870317Cohen L, Cole SW, Sood AK, Prinsloo S, Kirschbaum C, Arevalo JM, Jennings NB, Scott S, Vence L, Wei Q, Kentor D, Radvanyi L, Tannir N, Jonasch E, Tamboli P, Pisters LPloS oneDepressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One. 2012; 7(8):e42324.PLoS One2012-08-01T00:00:002012Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling.23273681Margulis V, Shariat SF, Rapoport Y, Rink M, Sjoberg DD, Tannir NM, Abel EJ, Culp SH, Tamboli P, Wood CGEuropean urologyDevelopment of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Eur Urol. 2013 May; 63(5):947-52.Eur Urol2012-11-23T00:00:002012Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.Authorship 2408824Authorship 2410433Authorship 2416081Authorship 2422991Authorship 2430672Authorship 2435283Authorship 2440944Authorship 2445392Authorship 2449854Authorship 2466382Authorship 2466861Authorship 2492765Authorship 2497632Authorship 2500348Authorship 2504154Authorship 2504442Authorship 2509415Authorship 2515473Authorship 2516593Authorship 2531863Authorship 2531972Authorship 2535728Authorship 2543706Authorship 2557987Authorship 2560706Authorship 2570805Authorship 2574223Authorship 2575531Authorship 2589854Authorship 26246459796733Hailemariam S, Gaspert A, Komminoth P, Tamboli P, Amin MModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncPrimary, pure, large-cell neuroendocrine carcinoma of the urinary bladder. Mod Pathol. 1998 Oct; 11(10):1016-20.Mod Pathol1998-10-01T00:00:001998Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder.10197234Ligato S, Ro JY, Tamboli P, Amin MB, Ayala AGAdvances in anatomic pathologyBenign tumors and tumor-like lesions of the adult kidney. Part I: Benign renal epithelial neoplasms. Adv Anat Pathol. 1999 Jan; 6(1):1-11.Adv Anat Pathol1999-01-01T00:00:001999Benign tumors and tumor-like lesions of the adult kidney. Part I: Benign renal epithelial neoplasms.10640201Tamboli P, Ro JY, Amin MB, Ligato S, Ayala AGAdvances in anatomic pathologyBenign tumors and tumor-like lesions of the adult kidney. Part II: Benign mesenchymal and mixed neoplasms, and tumor-like lesions. Adv Anat Pathol. 2000 Jan; 7(1):47-66.Adv Anat Pathol2000-01-01T00:00:002000Benign tumors and tumor-like lesions of the adult kidney. Part II: Benign mesenchymal and mixed neoplasms, and tumor-like lesions.10721414Tamboli P, Ro JYAdvances in anatomic pathologyVillous adenoma of urinary tract: a common tumor in an uncommon location. Adv Anat Pathol. 2000 Mar; 7(2):79-84.Adv Anat Pathol2000-03-01T00:00:002000Villous adenoma of urinary tract: a common tumor in an uncommon location.11717541Merchant SH, Amin MB, Tamboli P, Ro J, Ord??ez NG, Ayala AG, Czerniak BA, Ro JYThe American journal of surgical pathologyPrimary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol. 2001 Dec; 25(12):1515-9.Am J Surg Pathol2001-12-01T00:00:002001Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.11859208Amin MB, Tamboli P, Merchant SH, Ord??ez NG, Ro J, Ayala AG, Ro JYThe American journal of surgical pathologyMicropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002 Mar; 26(3):358-64.Am J Surg Pathol2002-03-01T00:00:002002Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance.11939729Copeland JN, Amin MB, Humphrey PA, Tamboli P, Ro JY, Gal AAAmerican journal of clinical pathologyThe morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms. Am J Clin Pathol. 2002 Apr; 117(4):552-7.Am J Clin Pathol2002-04-01T00:00:002002The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms.12162678Varma M, Morgan M, Jasani B, Tamboli P, Amin MBAmerican journal of clinical pathologyPolyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology. Am J Clin Pathol. 2002 Aug; 118(2):202-7.Am J Clin Pathol2002-08-01T00:00:002002Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology.12715336Toprani TH, Tamboli P, Amin MB, Ordo?ez NG, Ayala AG, Ro JYAnnals of diagnostic pathologyThymic carcinoma with rhabdoid features. Ann Diagn Pathol. 2003 Apr; 7(2):106-11.Ann Diagn Pathol2003-04-01T00:00:002003Thymic carcinoma with rhabdoid features.14745719Tamboli P, Toprani TH, Amin MB, Ro JS, Ord??ez NG, Ayala AG, Ro JYHuman pathologyCarcinoma of lung with rhabdoid features. Hum Pathol. 2004 Jan; 35(1):8-13.Hum Pathol2004-01-01T00:00:002004Carcinoma of lung with rhabdoid features.15848739Abrahams NA, Tamboli PClinics in laboratory medicineOncocytic renal neoplasms: diagnostic considerations. Clin Lab Med. 2005 Jun; 25(2):317-39, vi.Clin Lab Med2005-06-01T00:00:002005Oncocytic renal neoplasms: diagnostic considerations.17306332Spiess PE, Tuziak T, Tibbs RF, Bassett R, Tamboli P, Brown GA, Grossman HB, Ayala AG, Czerniak BHuman pathologyPseudosarcomatous and sarcomatous proliferations of the bladder. Hum Pathol. 2007 May; 38(5):753-61.Hum Pathol2007-02-15T00:00:002007Pseudosarcomatous and sarcomatous proliferations of the bladder.17487856Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CGCancerRedefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Cancer. 2007 Jun 15; 109(12):2439-44.Cancer2007-06-15T00:00:002007Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.17509308Spiess PE, Izawa JI, Bassett R, Kedar D, Busby JE, Wong F, Eddings T, Tamboli P, Pettaway CAThe Journal of urologyPreoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation. J Urol. 2007 Jun; 177(6):2157-61.J Urol2007-06-01T00:00:002007Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation.17868729Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CGThe Journal of urologyCytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. J Urol. 2007 Nov; 178(5):1896-900.J Urol2007-09-17T00:00:002007Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.18485389Margulis V, Matin SF, Tannir N, Tamboli P, Swanson DA, Jonasch E, Wood CGThe Journal of urologySurgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J Urol. 2008 Jul; 180(1):94-8.J Urol2008-05-15T00:00:002008Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.18517262Ricketts R, Tamboli P, Czerniak B, Guo CCArchives of pathology & laboratory medicineTumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney. Arch Pathol Lab Med. 2008 Jun; 132(6):1016-20.Arch Pathol Lab Med2008-06-01T00:00:002008Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney.18824438Bilen MA, Waguespack SG, Tannir NM, Pravinkumar SE, Tamboli P, Tu SMClinical genitourinary cancerMultisystem crisis in a patient with presumptive renal cell carcinoma. Clin Genitourin Cancer. 2008 Sep; 6(2):128-30.Clin Genitourin Cancer2008-09-01T00:00:002008Multisystem crisis in a patient with presumptive renal cell carcinoma.19011563Nigwekar P, Tamboli P, Amin MB, Osunkoya AO, Ben-Dor D, Amin MBThe American journal of surgical pathologyPlasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases. Am J Surg Pathol. 2009 Mar; 33(3):417-24.Am J Surg Pathol2009-03-01T00:00:002009Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases.19118035Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S, Tsavachidou D, Tamboli P, Czerniak BA, Do KA, Wu KJ, Marlow LA, Wood CG, Copland JA, Walker CLClinical cancer research : an official journal of the American Association for Cancer ResearchCytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res. 2009 Jan 01; 15(1):81-90.Clin Cancer Res2009-01-01T00:00:002009Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.19286220Margulis V, McDonald M, Tamboli P, Swanson DA, Wood CGThe Journal of urologyPredictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol. 2009 May; 181(5):2044-51.J Urol2009-03-14T00:00:002009Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.19454359Guo CC, Gomez E, Tamboli P, Bondaruk JE, Kamat A, Bassett R, Dinney CP, Czerniak BAHuman pathologySquamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Hum Pathol. 2009 Oct; 40(10):1448-52.Hum Pathol2009-05-19T00:00:002009Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases.19862815Jonasch E, Corn P, Pagliaro LC, Warneke CL, Johnson MM, Tamboli P, Ng C, Aparicio A, Ashe RG, Wright JJ, Tannir NMCancerUpfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis. Cancer. 2010 Jan 01; 116(1):57-65.Cancer2010-01-01T00:00:002010Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis.20676129Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P, Wood CG, Wu XOncogeneHsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene. 2010 Oct 21; 29(42):5724-8.Oncogene2010-08-02T00:00:002010Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma.21621907Chapin BF, Delacroix SE, Culp SH, Nogueras Gonzalez GM, Tannir NM, Jonasch E, Tamboli P, Wood CGEuropean urologySafety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma. Eur Urol. 2011 Nov; 60(5):964-71.Eur Urol2011-05-25T00:00:002011Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma.21849197Delacroix SE, Chapin BF, Chen JJ, Nogueras-Gonzalez GM, Tamboli P, Matin SF, Wood CGThe Journal of urologyCan a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma? J Urol. 2011 Oct; 186(4):1236-41.J Urol2011-08-17T00:00:002011Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?22301499Rao P, Tannir NM, Tamboli PThe American journal of surgical pathologyExpression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfall. Am J Surg Pathol. 2012 Apr; 36(4):583-8.Am J Surg Pathol2012-04-01T00:00:002012Expression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfall.22706175Richey SL, Tamboli P, Ng CS, Lin E, Lim ZD, Araujo JC, Jonasch E, Sharma P, Pagliaro LC, Tannir NMAmerican journal of clinical oncologyPhase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma. Am J Clin Oncol. 2013 Oct; 36(5):450-4.Am J Clin Oncol2013-10-01T00:00:002013Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma.22771265Tannir NM, Plimack E, Ng C, Tamboli P, Bekele NB, Xiao L, Smith L, Lim Z, Pagliaro L, Araujo J, Aparicio A, Matin S, Wood CG, Jonasch EEuropean urologyA phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma. Eur Urol. 2012 Dec; 62(6):1013-9.Eur Urol2012-06-27T00:00:002012A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma.25025366Amin MB, Smith SC, Eble JN, Rao P, Choi WW, Tamboli P, Young RHThe American journal of surgical pathologyGlandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol. 2014 Aug; 38(8):1033-45.Am J Surg Pathol2014-08-01T00:00:002014Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification.Authorship 2649165Authorship 2649177Authorship 2655763Authorship 2664543Authorship 2665796Authorship 2669253Authorship 2673372Authorship 2687116Authorship 269868411257655Slaton JW, Morgenstern N, Levy DA, Santos MW, Tamboli P, Ro JY, Ayala AG, Pettaway CAThe Journal of urologyTumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol. 2001 Apr; 165(4):1138-42.J Urol2001-04-01T00:00:002001Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer.11266520Jimenez RE, Eble JN, Reuter VE, Epstein JI, Folpe AL, de Peralta-Venturina M, Tamboli P, Ansell ID, Grignon DJ, Young RH, Amin MBModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncConcurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases. Mod Pathol. 2001 Mar; 14(3):157-63.Mod Pathol2001-03-01T00:00:002001Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases.11859199Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon MThe American journal of surgical pathologyPrognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002 Mar; 26(3):281-91.Am J Surg Pathol2002-03-01T00:00:002002Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases.15028446Naya Y, Ayala AG, Tamboli P, Babaian RJUrologyCan the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy? Urology. 2004 Mar; 63(3):503-8.Urology2004-03-01T00:00:002004Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?16342249Johnson FM, Krug LM, Tran HT, Shoaf S, Prieto VG, Tamboli P, Peeples B, Patel J, Glisson BSCancerPhase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma. Cancer. 2006 Jan 15; 106(2):366-74.Cancer2006-01-15T00:00:002006Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.16527570Busby JE, Brown GA, Tamboli P, Kamat AM, Dinney CP, Grossman HB, Matin SFUrologyUpper urinary tract tumors with nontransitional histology: a single-center experience. Urology. 2006 Mar; 67(3):518-23.Urology2006-03-01T00:00:002006Upper urinary tract tumors with nontransitional histology: a single-center experience.17979923Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CGBJU internationalOncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int. 2007 Dec; 100(6):1235-9.BJU Int2007-12-01T00:00:002007Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.19240244Clague J, Lin J, Cassidy A, Matin S, Tannir NM, Tamboli P, Wood CG, Wu XCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyFamily history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):801-7.Cancer Epidemiol Biomarkers Prev2009-02-24T00:00:002009Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.20850148Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CGThe Journal of urologyPercutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment. J Urol. 2010 Nov; 184(5):1877-81.J Urol2010-09-17T00:00:002010Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment.Authorship 2732684Authorship 2739111Authorship 2741515Authorship 2765332Authorship 2773044Authorship 277850210435562Amin MB, Tamboli P, Varma M, Srigley JRThe American journal of surgical pathologyPostatrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens. Am J Surg Pathol. 1999 Aug; 23(8):925-31.Am J Surg Pathol1999-08-01T00:00:001999Postatrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens.11224597de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MBThe American journal of surgical pathologySarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001 Mar; 25(3):275-84.Am J Surg Pathol2001-03-01T00:00:002001Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.18022122Vakar-Lopez F, Shen SS, Zhang S, Tamboli P, Ayala AG, Ro JYAnnals of diagnostic pathologyMuscularis mucosae of the urinary bladder revisited with emphasis on its hyperplastic patterns: a study of a large series of cystectomy specimens. Ann Diagn Pathol. 2007 Dec; 11(6):395-401.Ann Diagn Pathol2007-10-24T00:00:002007Muscularis mucosae of the urinary bladder revisited with emphasis on its hyperplastic patterns: a study of a large series of cystectomy specimens.18240184Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CGCancerAnalysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer. 2008 Apr 01; 112(7):1480-8.Cancer2008-04-01T00:00:002008Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.20305615Chaux A, Tamboli P, Ayala A, Soares F, Rodr?guez I, Barreto J, Cubilla ALModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncWarty-basaloid carcinoma: clinicopathological features of a distinctive penile neoplasm. Report of 45 cases. Mod Pathol. 2010 Jun; 23(6):896-904.Mod Pathol2010-03-19T00:00:002010Warty-basaloid carcinoma: clinicopathological features of a distinctive penile neoplasm. Report of 45 cases.20952123Abel EJ, Culp SH, Tannir NM, Matin SF, Tamboli P, Jonasch E, Wood CGEuropean urologyPrimary tumor response to targeted agents in patients with metastatic renal cell carcinoma. Eur Urol. 2011 Jan; 59(1):10-5.Eur Urol2010-10-16T00:00:002010Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma.26536169Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Li J, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MD, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YS, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJ, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, Auman JT, Bartlett J, Bastacky S, Bergsten J, Blute ML, Boice L, Bollag RJ, Boyd J, Castle E, Chen YB, Cheville JC, Curley E, Davies B, DeVolk A, Dhir R, Dike L, Eckman J, Engel J, Harr J, Hrebinko R, Huang M, Huelsenbeck-Dill L, Iacocca M, Jacobs B, Lobis M, Maranchie JK, McMeekin S, Myers J, Nelson J, Parfitt J, Parwani A, Petrelli N, Rabeno B, Roy S, Salner AL, Slaton J, Stanton M, Thompson RH, Thorne L, Tucker K, Weinberger PM, Winemiller C, Zach LA, Zuna RThe New England journal of medicineComprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14; 374(2):135-45.N Engl J Med2015-11-04T00:00:002015Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.Authorship 2876854Authorship 2877597Authorship 2888864Authorship 2889317Authorship 2890439Authorship 2890524Authorship 28907510Authorship 2901052Authorship 2920174Authorship 29267029Authorship 29279110Authorship 29287713Authorship 2931402Authorship 29331111Authorship 2942297Authorship 2944859Authorship 2947075Authorship 30307411Authorship 30370911Authorship 30446516Authorship 304965924025521Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H, Tamboli P, Delahunt B, Egevad L, Montironi R, Srigley JR, members of the ISUP Renal Tumor PanelThe American journal of surgical pathologyHandling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol. 2013 Oct; 37(10):1505-17.Am J Surg Pathol2013-10-01T00:00:002013Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations.24128265Abel EJ, Carrasco A, Karam J, Tamboli P, Delacroix S, Vaporciyan AA, Wood CGBJU internationalPositive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus. BJU Int. 2014 Nov; 114(5):667-73.BJU Int2014-02-19T00:00:002014Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus.24518767Babaian KN, Merrill MM, Matin S, Tamboli P, Tannir NM, Jonasch E, Wood CG, Karam JAThe Journal of urologyPartial nephrectomy in the setting of metastatic renal cell carcinoma. J Urol. 2014 Jul; 192(1):36-42.J Urol2014-02-08T00:00:002014Partial nephrectomy in the setting of metastatic renal cell carcinoma.24560330Karam JA, Devine CE, Urbauer DL, Lozano M, Maity T, Ahrar K, Tamboli P, Tannir NM, Wood CGEuropean urologyPhase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. Eur Urol. 2014 Nov; 66(5):874-80.Eur Urol2014-02-07T00:00:002014Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.24587095Satcher RL, Pan T, Cheng CJ, Lee YC, Lin SC, Yu G, Li X, Hoang AG, Tamboli P, Jonasch E, Gallick GE, Lin SHPloS oneCadherin-11 in renal cell carcinoma bone metastasis. PLoS One. 2014; 9(2):e89880.PLoS One2014-02-24T00:00:002014Cadherin-11 in renal cell carcinoma bone metastasis.24589208Burch-Smith R, Tannir NM, Resetkova E, Tamboli P, Rao PChinese journal of cancerCollision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up. Chin J Cancer. 2014 Jul; 33(7):351-5.Chin J Cancer2014-03-04T00:00:002014Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up.24613583Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WKEuropean urologyClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul; 66(1):77-84.Eur Urol2014-02-25T00:00:002014ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.24953786Rao P, Tamboli P, Fillman EP, Meis JMPathology, research and practicePrimary intra-renal desmoplastic small round cell tumor: expanding the histologic spectrum, with special emphasis on the differential diagnostic considerations. Pathol Res Pract. 2014 Dec; 210(12):1130-3.Pathol Res Pract2014-05-23T00:00:002014Primary intra-renal desmoplastic small round cell tumor: expanding the histologic spectrum, with special emphasis on the differential diagnostic considerations.25390078Babaian KN, Kim DY, Kenney PA, Wood CG, Wong J, Sanchez C, Fang JE, Gerber JA, Didic A, Wahab A, Golla V, Torres C, Tamboli P, Qiao W, Matin SF, Wood CG, Karam JAThe Journal of urologyPreoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection. J Urol. 2015 Apr; 193(4):1101-7.J Urol2014-10-25T00:00:002014Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection.25395040Kenney PA, Vikram R, Prasad SR, Tamboli P, Matin SF, Wood CG, Karam JABJU internationalMucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes. BJU Int. 2015 Jul; 116(1):85-92.BJU Int2015-03-12T00:00:002015Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes.25476125Rao P, Tamboli PHuman pathologyDo clear cell papillary renal cell carcinomas occur in patients with von Hippel-Lindau disease?-Reply. Hum Pathol. 2015 Feb; 46(2):341-3.Hum Pathol2014-11-12T00:00:002014Do clear cell papillary renal cell carcinomas occur in patients with von Hippel-Lindau disease?-Reply.25499860Rioux-Leclercq N, Ferran A, Mahul A, Argani P, Billis A, Bonsib S, Cheng L, Cheville J, Eble J, Egevad L, Epstein J, Grignon D, Hes O, Humphrey P, Magi-Galluzzi C, Martignoni G, McKenney J, Merino M, Moch H, Montironi R, Netto G, Reuter V, Samaratunga H, Shen S, Srigley J, Tamboli P, Tan PH, Tickoo S, Trpkov K, Zhou M, Delahunt B, Comperat E, International Society of Urologic PathologyAnnales de pathologie[Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations]. Ann Pathol. 2014 Dec; 34(6):448-61.Ann Pathol2014-11-18T00:00:002014[Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations].25532962Begg CB, Seshan VE, Zabor EC, Furberg H, Arora A, Shen R, Maranchie JK, Nielsen ME, Rathmell WK, Signoretti S, Tamboli P, Karam JA, Choueiri TK, Hakimi AA, Hsieh JJBMC medical research methodologyGenomic investigation of etiologic heterogeneity: methodologic challenges. BMC Med Res Methodol. 2014 Dec 22; 14:138.BMC Med Res Methodol2014-12-22T00:00:002014Genomic investigation of etiologic heterogeneity: methodologic challenges.25542006Rasmussen NR, Debebe Z, Wright TM, Brooks SA, Sendor AB, Brannon AR, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Wallen EM, Simpson C, Norris JL, Janzen WP, Rathmell WKPloS oneExpression of Ror2 mediates invasive phenotypes in renal cell carcinoma. PLoS One. 2014; 9(12):e116101.PLoS One2014-12-26T00:00:002014Expression of Ror2 mediates invasive phenotypes in renal cell carcinoma.25700975Merrill MM, Wood CG, Tannir NM, Slack RS, Babaian KN, Jonasch E, Pagliaro LC, Compton Z, Tamboli P, Sircar K, Pisters LL, Matin SF, Karam JAUrologic oncologyClinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent. Urol Oncol. 2015 Apr; 33(4):166.e21-9.Urol Oncol2015-02-17T00:00:002015Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.25758610Thomas AZ, Adibi M, Borregales LD, Hoang LN, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JAThe Journal of urologySurgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy. J Urol. 2015 Aug; 194(2):316-22.J Urol2015-03-07T00:00:002015Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.25900027Ho TH, Liu XD, Huang Y, Warneke CL, Johnson MM, Hoang A, Tamboli P, Wang F, Jonasch EBMC cancerThe impact of FGFR1 and FRS2a expression on sorafenib treatment in metastatic renal cell carcinoma. BMC Cancer. 2015 Apr 18; 15:304.BMC Cancer2015-04-18T00:00:002015The impact of FGFR1 and FRS2a expression on sorafenib treatment in metastatic renal cell carcinoma.25970682Aron M, Chang E, Herrera L, Hes O, Hirsch MS, Comperat E, Camparo P, Rao P, Picken M, Michal M, Montironi R, Tamboli P, Monzon F, Amin MBThe American journal of surgical pathologyClear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor. Am J Surg Pathol. 2015 Jul; 39(7):873-88.Am J Surg Pathol2015-07-01T00:00:002015Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.26004164Adibi M, Thomas AZ, Borregales LD, Merrill MM, Slack RS, Chen HC, Sircar K, Murugan P, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JAUrologic oncologyPercentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation. Urol Oncol. 2015 Oct; 33(10):427.e17-23.Urol Oncol2015-05-23T00:00:002015Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.26014097Liu XD, Hoang A, Zhou L, Kalra S, Yetil A, Sun M, Ding Z, Zhang X, Bai S, German P, Tamboli P, Rao P, Karam JA, Wood C, Matin S, Zurita A, Bex A, Griffioen AW, Gao J, Sharma P, Tannir N, Sircar K, Jonasch ECancer immunology researchResistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma. Cancer Immunol Res. 2015 Sep; 3(9):1017-29.Cancer Immunol Res2015-05-26T00:00:002015Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma.26111976Singh RR, Murugan P, Patel LR, Voicu H, Yoo SY, Majewski T, Mehrotra M, Wani K, Tannir N, Karam JA, Jonasch E, Wood CG, Creighton CJ, Medeiros LJ, Broaddus RR, Tamboli P, Baggerly KA, Aldape KD, Czerniak B, Luthra R, Sircar KModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncIntratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy. Mod Pathol. 2015 Sep; 28(9):1225-35.Mod Pathol2015-06-26T00:00:002015Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy.74Professor14Associate Professor26073078Ho TH, Park IY, Zhao H, Tong P, Champion MD, Yan H, Monzon FA, Hoang A, Tamboli P, Parker AS, Joseph RW, Qiao W, Dykema K, Tannir NM, Castle EP, Nunez-Nateras R, Teh BT, Wang J, Walker CL, Hung MC, Jonasch EOncogeneHigh-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene. 2016 Mar 24; 35(12):1565-74.Oncogene2015-06-15T00:00:002015High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.26947078Chen F, Zhang Y, Senbabaoglu Y, Ciriello G, Yang L, Reznik E, Shuch B, Micevic G, De Velasco G, Shinbrot E, Noble MS, Lu Y, Covington KR, Xi L, Drummond JA, Muzny D, Kang H, Lee J, Tamboli P, Reuter V, Shelley CS, Kaipparettu BA, Bottaro DP, Godwin AK, Gibbs RA, Getz G, Kucherlapati R, Park PJ, Sander C, Henske EP, Zhou JH, Kwiatkowski DJ, Ho TH, Choueiri TK, Hsieh JJ, Akbani R, Mills GB, Hakimi AA, Wheeler DA, Creighton CJCell reportsMultilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep. 2016 Mar 15; 14(10):2476-89.Cell Rep2016-03-03T00:00:002016Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.17240302Shen SS, Ro JY, Tamboli P, Truong LD, Zhai Q, Jung SJ, Tibbs RG, Ordonez NG, Ayala AGAnnals of diagnostic pathologyMucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. Ann Diagn Pathol. 2007 Feb; 11(1):13-21.Ann Diagn Pathol2007-02-01T00:00:002007Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features.20153508Contreras AL, Punar M, Tamboli P, Tu SM, Pisters L, Moran C, Czerniak BA, Guo CCHuman pathologyMediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases. Hum Pathol. 2010 Jun; 41(6):832-7.Hum Pathol2010-02-12T00:00:002010Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases.Authorship 3741926023237216Sircar K, Rao P, Jonasch E, Monzon FA, Tamboli PChinese journal of cancerContemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features. Chin J Cancer. 2013 Jun; 32(6):303-11.Chin J Cancer2012-12-07T00:00:002012Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features.19561445Guo CC, Punar M, Contreras AL, Tu SM, Pisters L, Tamboli P, Czerniak BThe American journal of surgical pathologyTesticular germ cell tumors with sarcomatous components: an analysis of 33 cases. Am J Surg Pathol. 2009 Aug; 33(8):1173-8.Am J Surg Pathol2009-08-01T00:00:002009Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases.27256309Malouf GG, Su X, Zhang J, Creighton CJ, Ho TH, Lu Y, Raynal NJ, Karam JA, Tamboli P, Allanick F, Mouawad R, Spano JP, Khayat D, Wood CG, Jelinek J, Tannir NMClinical cancer research : an official journal of the American Association for Cancer ResearchDNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas. Clin Cancer Res. 2016 Dec 15; 22(24):6236-6246.Clin Cancer Res2016-06-02T00:00:002016DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.20586628Fang X, Gupta N, Shen SS, Tamboli P, Charnsangavej C, Rashid A, Wang HArchives of pathology & laboratory medicineIntraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp. Arch Pathol Lab Med. 2010 Jul; 134(7):1003-9.Arch Pathol Lab Med2010-07-01T00:00:002010Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp.26364599Zhou L, Liu XD, Sun M, Zhang X, German P, Bai S, Ding Z, Tannir N, Wood CG, Matin SF, Karam JA, Tamboli P, Sircar K, Rao P, Rankin EB, Laird DA, Hoang AG, Walker CL, Giaccia AJ, Jonasch EOncogeneTargeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene. 2016 05; 35(21):2687-97.Oncogene2015-09-14T00:00:002015Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.Authorship 841157Authorship 842420Authorship 843297Authorship 843806Authorship 845245Authorship 845782Authorship 845799Authorship 847022Authorship 847674Authorship 847945Authorship 847992Authorship 849313Authorship 849691Authorship 850450Authorship 851617Authorship 852038Authorship 852264Authorship 853907Authorship 854418Authorship 855523Authorship 855715Authorship 855833Authorship 857507Authorship 859162Authorship 859642Authorship 859684Authorship 860192Authorship 860326Authorship 860951Authorship 861214Authorship 862519Authorship 862774Authorship 862990Authorship 863941Authorship 864272Authorship 866578Authorship 867071BMC CancerThe impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma. BMC Cancer. 15.The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinomaAmerican Journal of Surgical PathologyClear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease. American Journal of Surgical Pathology. 39:873-888.Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal diseaseBJU InternationalPrognosis of patients with metastatic renal cell carcinoma and pancreatic metastases. BJU International. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastasesHuman PathologySecondary malignancies diagnosed using kidney needle core biopsies. Human Pathology. 52:55-60.Secondary malignancies diagnosed using kidney needle core biopsiesHuman PathologyNecrosis assessment in renal carcinoma-reply. Human Pathology. 43:151-152.Necrosis assessment in renal carcinoma-replyBJU InternationalFactors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. BJU International. Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinomaHuman PathologyAdenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma. Human Pathology. 58:138-144.Adenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinomaOncogeneTargeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinomaAnnales de PathologieLes tumeurs rénales. Annales de Pathologie. 34:448-461.Les tumeurs rénalesOncogeneHigh-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinomaPathologic considerations. 17-28.Pathologic considerationsUrologic Oncology: Seminars and Original InvestigationsPrognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy. Urologic Oncology: Seminars and Original Investigations. Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomyModern PathologyIntratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma. Modern Pathology. 28:1225-1235.Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinomaEuropean UrologyGenomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations. European Urology. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic AlterationsClinical Cancer ResearchDNA methylation signature reveals cell ontogeny of renal cell carcinomas. Clinical Cancer Research. 22:6236-6246.DNA methylation signature reveals cell ontogeny of renal cell carcinomasBJU InternationalMucinous tubular and spindle cell carcinoma (MTSCC) of the kidney. BJU International. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidneyAmerican Journal of Surgical PathologyRenal tumors. American Journal of Surgical Pathology. 37:1518-1531.Renal tumorsCell ReportsMultilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Reports. 14:2476-2489.Multilevel Genomics-Based Taxonomy of Renal Cell CarcinomaJournal of UrologyRenal cell carcinoma clinically involving adjacent organs. Journal of Urology. 179:496-497.Renal cell carcinoma clinically involving adjacent organsPenis and Scrotum. 1181-1196.Penis and ScrotumCancer immunology researchResistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic Renal cell carcinoma. Cancer immunology research. 3:1017-1029.Resistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic Renal cell carcinomaUrologic Oncology: Seminars and Original InvestigationsClinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation. Urologic Oncology: Seminars and Original Investigations. 33:166.e21-166.e29.Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiationRenal angiomyolipoma. 565-586.Renal angiomyolipomaJournal of UrologySurgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy. Journal of Urology. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical NephrectomyBJU InternationalManagement and outcomes of patients with renal medullary carcinoma. BJU International. Management and outcomes of patients with renal medullary carcinomaAmerican Journal of Surgical PathologyHandling and staging of renal cell carcinoma. American Journal of Surgical Pathology. 37:1505-1517.Handling and staging of renal cell carcinomaUrologic Oncology: Seminars and Original InvestigationsPercentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation. Urologic Oncology: Seminars and Original Investigations. 33:427.e17-427.e23.Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiationJournal of UrologyThe Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation. Journal of Urology. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid DedifferentiationOncogeneGenomic profiling identifies alterations in TGFβ signaling through loss of TGFβ receptor expression in human renal cell carcinogenesis and progression. Oncogene. 22:8053-8062.Genomic profiling identifies alterations in TGFβ signaling through loss of TGFβ receptor expression in human renal cell carcinogenesis and progressionRadiographicsAuthors' response. Radiographics. 29:757.Authors' responseBJU InternationalMetastases to the kidney. BJU International. Metastases to the kidneyEuropean UrologyPhase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. European Urology. 66:874-880.Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinomaEuropean UrologyEverolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN). European Urology. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN)BMC Medical Research MethodologyGenomic investigation of etiologic heterogeneity. BMC Medical Research Methodology. 14.Genomic investigation of etiologic heterogeneityAmerican Journal of Surgical PathologyThe International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. American Journal of Surgical Pathology. 37:1469-1489.The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasiaTestis and Paratestis Including Spermatic Cord. 1197-1234.Testis and Paratestis Including Spermatic CordCancer immunology researchTumor mutational load and immune parameters across metastatic renal cell carcinoma risk groups. Cancer immunology research. 4:820-822.Tumor mutational load and immune parameters across metastatic renal cell carcinoma risk groups28710314Wang Z, Kim TB, Peng B, Karam J, Creighton C, Joon A, Kawakami F, Trevisan P, Jonasch E, Chow CW, Canales JR, Tamboli P, Tannir N, Wood C, Monzon F, Baggerly K, Varella-Garcia M, Czerniak B, Wistuba I, Mills G, Shaw K, Chen K, Sircar KClinical cancer research : an official journal of the American Association for Cancer ResearchSarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape. Clin Cancer Res. 2017 Nov 01; 23(21):6686-6696.Clin Cancer Res2017-07-14T00:00:002017Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.29617669Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG, Cancer Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WMCell reportsThe Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 04 03; 23(1):313-326.e5.Cell Rep2018-04-03T00:00:002018The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.23444225Zhao Q, Caballero OL, Davis ID, Jonasch E, Tamboli P, Yung WK, Weinstein JN, Kenna Shaw for TCGA research network, Strausberg RL, Yao JClinical cancer research : an official journal of the American Association for Cancer ResearchTumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas. Clin Cancer Res. 2013 May 01; 19(9):2460-72.Clin Cancer Res2013-02-26T00:00:002013Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.Authorship 88740119Authorship 8875029Authorship 88778812Authorship 88888512Authorship 8890237Authorship 89007535D009392Procedures1837740.685511NephrectomyD002291Disorders2455840.734765Carcinoma, PapillaryD002292Disorders43623170.406865Carcinoma, Renal CellD010412Disorders651580.8469Penile NeoplasmsD007680Disorders57230120.367869Kidney NeoplasmsAuthorship 9041717Authorship 9044772Authorship 9054337Authorship 9056865Authorship 9061717Authorship 90728313Authorship 9077204Authorship 9085084Authorship 90882610Authorship 9091086Authorship 9096815Authorship 91022910Authorship 9107782Authorship 9121103Authorship 91257514Authorship 9160229Authorship 9183406Authorship 9183594Authorship 9183706Authorship 9216097Authorship 9216513Authorship 9231669Authorship 9291318Authorship 93302935Authorship 93535625Authorship 938532826053895Zhou C, Urbauer DL, Fellman BM, Tamboli P, Zhang M, Matin SF, Wood CG, Karam JABJU internationalMetastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre. BJU Int. 2016 May; 117(5):775-82.BJU Int2015-07-05T00:00:002015Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre.26032863Kalra S, Atkinson BJ, Matrana MR, Matin SF, Wood CG, Karam JA, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch EBJU internationalPrognosis of patients with metastatic renal cell carcinoma and pancreatic metastases. BJU Int. 2016 May; 117(5):761-5.BJU Int2015-07-06T00:00:002015Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.26626617Tannir NM, Jonasch E, Albiges L, Altinmakas E, Ng CS, Matin SF, Wang X, Qiao W, Dubauskas Lim Z, Tamboli P, Rao P, Sircar K, Karam JA, McDermott DF, Wood CG, Choueiri TKEuropean urologyEverolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial. Eur Urol. 2016 05; 69(5):866-74.Eur Urol2015-11-26T00:00:002015Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.26839909Ghosh P, Tamboli P, Vikram R, Rao AJournal of medical imaging (Bellingham, Wash.)Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features. J Med Imaging (Bellingham). 2015 Oct; 2(4):041009.J Med Imaging (Bellingham)2015-10-06T00:00:002015Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features.26895810Malouf GG, Ali SM, Wang K, Balasubramanian S, Ross JS, Miller VA, Stephens PJ, Khayat D, Pal SK, Su X, Sircar K, Tamboli P, Jonasch E, Tannir NM, Wood CG, Karam JAEuropean urologyGenomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations. Eur Urol. 2016 08; 70(2):348-57.Eur Urol2016-02-16T00:00:002016Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.26707613Borregales LD, Kim DY, Staller AL, Qiao W, Thomas AZ, Adibi M, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JAUrologic oncologyPrognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy. Urol Oncol. 2016 May; 34(5):237.e19-26.Urol Oncol2015-12-18T00:00:002015Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy.27036304Thomas AZ, Adibi M, Slack RS, Borregales LD, Merrill MM, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JAThe Journal of urologyThe Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis. J Urol. 2016 Sep; 196(3):678-84.J Urol2016-03-29T00:00:002016The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.27499906Sircar K, Yoo SY, Majewski T, Wani K, Patel LR, Voicu H, Torres-Garcia W, Verhaak RG, Tannir N, Karam JA, Jonasch E, Wood CG, Tamboli P, Baggerly KA, Aldape KD, Czerniak BThe journal of pathology. Clinical researchBiphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomas. J Pathol Clin Res. 2015 Oct; 1(4):212-24.J Pathol Clin Res2015-07-07T00:00:002015Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomas.27554206Zhang M, Pettaway C, Vikram R, Tamboli PHuman pathologyAdenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma: a detailed clinicopathologic case report and review of the literature. Hum Pathol. 2016 12; 58:138-144.Hum Pathol2016-08-20T00:00:002016Adenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma: a detailed clinicopathologic case report and review of the literature.26980018Huang H, Tamboli P, Karam JA, Vikram R, Zhang MHuman pathologySecondary malignancies diagnosed using kidney needle core biopsies: a clinical and pathological study of 75 cases. Hum Pathol. 2016 06; 52:55-60.Hum Pathol2016-02-01T00:00:002016Secondary malignancies diagnosed using kidney needle core biopsies: a clinical and pathological study of 75 cases.27753187Reddy JP, Pettaway CA, Levy LB, Pagliaro LC, Tamboli P, Rao P, Jayaratna I, Hoffman KEBJU internationalFactors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. BJU Int. 2017 04; 119(4):591-597.BJU Int2016-11-08T00:00:002016Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma.27860149Shah AY, Karam JA, Malouf GG, Rao P, Lim ZD, Jonasch E, Xiao L, Gao J, Vaishampayan UN, Heng DY, Plimack ER, Guancial EA, Fung C, Lowas SR, Tamboli P, Sircar K, Matin SF, Kimryn Rathmell W, Wood CG, Tannir NMBJU internationalManagement and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study. BJU Int. 2017 12; 120(6):782-792.BJU Int2016-12-09T00:00:002016Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.27538576de Velasco G, Miao D, Voss MH, Hakimi AA, Hsieh JJ, Tannir NM, Tamboli P, Appleman LJ, Rathmell WK, Van Allen EM, Choueiri TKCancer immunology researchTumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups. Cancer Immunol Res. 2016 10; 4(10):820-822.Cancer Immunol Res2016-08-18T00:00:002016Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups.27678298Kawakami F, Rao P, Tamboli P, Wood CG, Karam JAThe Journal of urologyStudy of the Kidney Tumor-Parenchymal Interface after Neoadjuvant Treatment with Axitinib for Locally Advanced Clear Cell Renal Cell Carcinoma: Matched Analysis from a Phase II Trial. J Urol. 2017 03; 197(3 Pt 1):559-565.J Urol2016-09-25T00:00:002016Study of the Kidney Tumor-Parenchymal Interface after Neoadjuvant Treatment with Axitinib for Locally Advanced Clear Cell Renal Cell Carcinoma: Matched Analysis from a Phase II Trial.28216278Kalra S, Verma J, Atkinson BJ, Matin SF, Wood CG, Karam JA, Lin SH, Satcher RL, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch EClinical genitourinary cancerOutcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era. Clin Genitourin Cancer. 2017 06; 15(3):363-370.Clin Genitourin Cancer2017-01-18T00:00:002017Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.28220024de Velasco G, Culhane AC, Fay AP, Hakimi AA, Voss MH, Tannir NM, Tamboli P, Appleman LJ, Bellmunt J, Kimryn Rathmell W, Albiges L, Hsieh JJ, Heng DY, Signoretti S, Choueiri TKThe oncologistMolecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model. Oncologist. 2017 03; 22(3):286-292.Oncologist2017-02-20T00:00:002017Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.28429277Murugan P, Rao P, Tamboli P, Czerniak B, Guo CCPathology oncology research : PORPrimary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases. Pathol Oncol Res. 2018 Jan; 24(1):153-159.Pathol Oncol Res2017-04-20T00:00:002017Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases.28411072Keskin SK, Msaouel P, Hess KR, Yu KJ, Matin SF, Sircar K, Tamboli P, Jonasch E, Wood CG, Karam JA, Tannir NMThe Journal of urologyOutcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras. J Urol. 2017 09; 198(3):530-537.J Urol2017-04-11T00:00:002017Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.28941919Wood EL, Adibi M, Qiao W, Brandt J, Zhang M, Tamboli P, Matin SF, Wood CG, Karam JAThe Journal of urologyLocal Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses. J Urol. 2018 02; 199(2):393-400.J Urol2017-09-20T00:00:002017Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.28827100Zhang M, Adeniran AJ, Vikram R, Tamboli P, Pettaway C, Bondaruk J, Liu J, Baggerly K, Czerniak BHuman pathologyCarcinoma of the urethra. Hum Pathol. 2018 02; 72:35-44.Hum Pathol2017-08-18T00:00:002017Carcinoma of the urethra.28832979Kawakami F, Sircar K, Rodriguez-Canales J, Fellman BM, Urbauer DL, Tamboli P, Tannir NM, Jonasch E, Wistuba II, Wood CG, Karam JACancerProgrammed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation. Cancer. 2017 Dec 15; 123(24):4823-4831.Cancer2017-08-22T00:00:002017Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.29578041Petros FG, Keskin SK, Yu KJ, Li R, Metcalfe MJ, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CGUrologyIntraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes. Urology. 2018 Jun; 116:114-119.Urology2018-03-22T00:00:002018Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes.29488096Petros FG, Metcalfe MJ, Yu KJ, Keskin SK, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CGWorld journal of urologyOncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience. World J Urol. 2018 Jul; 36(7):1093-1101.World J Urol2018-02-27T00:00:002018Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.29925010Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG, Cancer Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WMCell reportsThe Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Jun 19; 23(12):3698.Cell Rep2018-06-19T00:00:002018The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.30276798Yu KJ, Keskin SK, Meissner MA, Petros FG, Wang X, Borregales LD, Gu C, Tamboli P, Matin SF, Wood CG, Karam JACancerRenal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging. Cancer. 2018 10 15; 124(20):4023-4031.Cancer2018-10-01T00:00:002018Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging.29878933Williamson SR, Rao P, Hes O, Epstein JI, Smith SC, Picken MM, Zhou M, Tretiakova MS, Tickoo SK, Chen YB, Reuter VE, Fleming S, Maclean FM, Gupta NS, Kuroda N, Delahunt B, Mehra R, Przybycin CG, Cheng L, Eble JN, Grignon DJ, Moch H, Lopez JI, Kunju LP, Tamboli P, Srigley JR, Amin MB, Martignoni G, Hirsch MS, Bonsib SM, Trpkov KThe American journal of surgical pathologyChallenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists. Am J Surg Pathol. 2018 09; 42(9):1253-1261.Am J Surg Pathol2018-09-01T00:00:002018Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists.PathologyUrology23551865Lewis RE, Cahyame-Zuniga L, Leventakos K, Chamilos G, Ben-Ami R, Tamboli P, Tarrand J, Bodey GP, Luna M, Kontoyiannis DPMycosesEpidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013 Nov; 56(6):638-45.Mycoses2013-04-04T00:00:002013Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study.23792563Cancer Genome Atlas Research NetworkNatureComprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 04; 499(7456):43-9.Nature2013-06-23T00:00:002013Comprehensive molecular characterization of clear cell renal cell carcinoma.23817689Malouf GG, Monzon FA, Couturier J, Molini? V, Escudier B, Camparo P, Su X, Yao H, Tamboli P, Lopez-Terrada D, Picken M, Garcia M, Multani AS, Pathak S, Wood CG, Tannir NMClinical cancer research : an official journal of the American Association for Cancer ResearchGenomic heterogeneity of translocation renal cell carcinoma. Clin Cancer Res. 2013 Sep 01; 19(17):4673-84.Clin Cancer Res2013-07-01T00:00:002013Genomic heterogeneity of translocation renal cell carcinoma.Authorship 9504642431231128Ruiz-Cordero R, Rao P, Li L, Qi Y, Atherton D, Peng B, Singh RR, Kim TB, Kawakami F, Routbort MJ, Alouch N, Chow CB, Tang X, Lu W, Brimo F, Matin SF, Wood CG, Tannir NM, Wistuba II, Chen K, Wang J, Medeiros LJ, Karam JA, Tamboli P, Sircar KModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncHybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma. Mod Pathol. 2019 11; 32(11):1698-1707.Mod Pathol2019-06-23T00:00:002019Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.Authorship 988486532358507Huang T, Cheng X, Chahoud J, Sarhan A, Tamboli P, Rao P, Guo M, Manyam G, Zhang L, Xiang Y, Han L, Shang X, Deng P, Luo Y, Lu X, Feng S, Ferrer MM, Alan Wang Y, DePinho RA, Pettaway CA, Lu XNature communicationsEffective combinatorial immunotherapy for penile squamous cell carcinoma. Nat Commun. 2020 05 01; 11(1):2124.Nat Commun2020-05-01T00:00:002020Effective combinatorial immunotherapy for penile squamous cell carcinoma.Authorship 9926762032586940Cowman SJ, Fuja DG, Liu XD, Tidwell RSS, Kandula N, Sirohi D, Agarwal AM, Emerson LL, Tripp SR, Mohlman JS, Stonhill M, Garcia G, Conley CJ, Olalde AA, Sargis T, Ramirez-Torres A, Karam JA, Wood CG, Sircar K, Tamboli P, Boucher K, Maughan B, Spike BT, Ho TH, Agarwal N, Jonasch E, Koh MYClinical cancer research : an official journal of the American Association for Cancer ResearchMacrophage HIF-1a Is an Independent Prognostic Indicator in Kidney Cancer. Clin Cancer Res. 2020 09 15; 26(18):4970-4982.Clin Cancer Res2020-06-25T00:00:002020Macrophage HIF-1a Is an Independent Prognostic Indicator in Kidney Cancer.Authorship 1012081933612354Kokorovic A, Duplisea J, Qiao W, McCormick B, Adibi M, Papadopoulos J, Ramirez G, Rao P, Tamboli P, Pettaway CUrologic oncologyOncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience. Urol Oncol. 2021 05; 39(5):302.e19-302.e27.Urol Oncol2021-02-18T00:00:002021Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience.Authorship 10201362034074655Cowman SJ, Fuja DG, Liu XD, Tidwell RSS, Kandula N, Sirohi D, Agarwal AM, Emerson LL, Tripp SR, Mohlman JS, Stonhill M, Garcia G, Conley CJ, Olalde AA, Sargis T, Ramirez-Torres A, Karam JA, Wood CG, Sircar K, Tamboli P, Boucher K, Maughan B, Spike BT, Ho TH, Agarwal N, Jonasch E, Koh MYClinical cancer research : an official journal of the American Association for Cancer ResearchCorrection: Macrophage HIF-1a Is an Independent Prognostic Indicator in Kidney Cancer. Clin Cancer Res. 2021 Jun 01; 27(11):3265.Clin Cancer Res2021-06-01T00:00:002021Correction: Macrophage HIF-1a Is an Independent Prognostic Indicator in Kidney Cancer.Authorship 1031256634625389Wilson NR, Wiele AJ, Surasi DS, Rao P, Sircar K, Tamboli P, Shah AY, Genovese G, Karam JA, Wood CG, Tannir NM, Msaouel PClinical genitourinary cancerEfficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma. Clin Genitourin Cancer. 2021 12; 19(6):e401-e408.Clin Genitourin Cancer2021-09-15T00:00:002021Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.Authorship 1036212434963688Falahkheirkhah K, Guo T, Hwang M, Tamboli P, Wood CG, Karam JA, Sircar K, Bhargava RLaboratory investigation; a journal of technical methods and pathologyA generative adversarial approach to facilitate archival-quality histopathologic diagnoses from frozen tissue sections. Lab Invest. 2022 05; 102(5):554-559.Lab Invest2021-12-28T00:00:002021A generative adversarial approach to facilitate archival-quality histopathologic diagnoses from frozen tissue sections.Authorship 1038017535261807Tsai CW, Chang WS, Xu Y, Huang M, Tamboli P, Wood CG, Bau DT, Gu JAmerican journal of cancer researchPrognostic significance of circulating insulin growth-like factor 1 and insulin growth-like factor binding protein 3 in renal cell carcinoma patients. Am J Cancer Res. 2022; 12(2):852-860.Am J Cancer Res2022-02-15T00:00:002022Prognostic significance of circulating insulin growth-like factor 1 and insulin growth-like factor binding protein 3 in renal cell carcinoma patients.Authorship 1049807134991194Tamboli P, Bharadwaj A, Chaurasiya A, Bangar YC, Jerome AAnimal bioscienceAssociation between age at first calving, first lactation traits and lifetime productivity in Murrah buffaloes. Anim Biosci. 2022 Aug; 35(8):1151-1161.Anim Biosci2022-01-05T00:00:002022Association between age at first calving, first lactation traits and lifetime productivity in Murrah buffaloes.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor25081542Rao P, Monzon F, Jonasch E, Matin SF, Tamboli PHuman pathologyClear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases. Hum Pathol. 2014 Sep; 45(9):1966-72.Hum Pathol2014-06-18T00:00:002014Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases.25155756Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA, The?Cancer Genome Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJCancer cellThe somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 08; 26(3):319-330.Cancer Cell2014-08-21T00:00:002014The somatic genomic landscape of chromophobe renal cell carcinoma.